Form 8-K - Current report:
SEC Accession No. 0001493152-20-005802
Filing Date
2020-04-03
Accepted
2020-04-03 17:00:15
Documents
7
Period of Report
2020-03-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 44779
2 ex4-1.htm EX-4.1 119388
3 ex4-2.htm EX-4.2 125712
4 ex4-3.htm EX-4.3 131495
5 ex4-4.htm EX-4.4 127149
6 ex10-1.htm EX-10.1 278656
7 ex10-2.htm EX-10.2 192516
  Complete submission text file 0001493152-20-005802.txt   1021097
Mailing Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124
Business Address 302/6 BUTLER STREET CAMBERWELL, VICTORIA C3 3124 613-9882-6723
Propanc Biopharma, Inc. (Filer) CIK: 0001517681 (see all company filings)

EIN.: 300662986 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-54878 | Film No.: 20774308
SIC: 2834 Pharmaceutical Preparations